Best investing defensive sectors like utilities rose 0

Defensive sectors like utilities rose 0.8% as bond yields eased. For "best investing", utilities with strong cash flow stability and moderate P/E ratios offer low-volatility returns. This is just not an anecdotal observation. It's backed up by more than 10 years of data. Since 2013, Bitcoin has increased in value by 20% in October, 46% in November, and another 5% in December. Consumer health company Kenvue is new to our list of best companies to buy this month. Formerly known as Johnson & Johnson’s JNJ consumer segment, the firm spun off and went public in 2023. Kenvue’s portfolio includes Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Kenvue’s share price dropped following a statement from the US Department of Health and Human Services on the potential link between acetaminophen use during pregnancy and autism, but Morningstar analyst Keonhee Kim doesn’t predict significant demand headwinds to Tylenol on a global level as the release lacked evidence of a causal link. However, more plaintiffs could emerge for ongoing Tylenol lawsuits. Kenvue still has a strong portfolio and has been able to stay ahead of its markets in terms of price hikes, and we expect this trend to continue thanks to its products’ brand power. Kenvue shares are trading 33% below our fair value estimate of $24.50. Latest analysis shows the S&P 500 dipping 0.3% today amid profit-taking, while tech-heavy Nasdaq remains flat. For "best investing" strategies, analysts eye AI-driven semiconductor stocks like NVDA and AMD, projecting Q3 revenue growth above 20%, making them potential outperformers into